Trial Details

COMPLETED
Basic Information
Clinical ID c1447
Identifier NCT01506362
Trial Title Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: BL-7040
Participant Information
Sponsor BioLineRx, Ltd.
City Be'er Sheva
Country/Region Israel
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-03-12
Primary Completion Date 2025-05-13
Completion Date 2025-05-13